David G Schwartz, PhD, and Stephen Lankenau, PhD, on Opioid Overdose Reversal in the Community Setting
David G Schwartz, PhD, and Stephen Lankenau, PhD, answer our questions on the results of a study examining the effectiveness of equipping members of the community with naloxone and a smartphone application to signal suspected opioid overdose.
In this Q&A, Sat Bir S. Khalsa, PhD, answered our questions about his team’s study that evaluated the efficacy of yoga vs cognitive behavioral therapy vs stress education for the treatment of generalized anxiety disorder.
How is adolescent e-cigarette use associated with later cigarette and smokeless tobacco use? In this Q&A, Brittney Keller-Hamilton, PhD, MPH, answered our questions about her team’s study examining this relationship.
The COLDICE study examined the effectiveness and safety of a novel, less-invasive approach to sampling lung tissue for the diagnosis of interstitial lung disease compared with the gold-standard surgical approach. Lead author Lauren Troy, PhD, answered our questions.
Jason J. Ong, PhD, MBBS, from the London School of Hygiene and Tropical Medicine, answers our questions about his team’s research on STI prevalence and incidence among new and persistent users of pre-exposure prophylaxis for HIV infection.
Barbara Levy, MD, clinical professor of obstetrics and gynecology at The George Washington University School of Medicine, discusses the findings of a recent study on the potential for laparoscopic radiofrequency ablation as a uterus-sparing treatment option for Black women with uterine fibroids.
It is well-known that patients’ blood pressure often elevates in the presence of pain. In a recent study, Elizabeth Pfoh, PhD, MPH, and her colleagues examined how elevated blood pressure and pain status impacted how physicians modified medication regimens. In this Q&A, Dr. Pfoh answered our questions about the study.
Biologic therapies have been introduced as new treatment options for patients with severe asthma. Wendy Moore, MD, answered our questions about the research she presented at CHEST2020.a
Consultant360 spoke with Richard J. Santen, MD, whose recent paper shed light on the importance of determining the underlying risk of breast cancer for individual patients before initiating menopausal hormone therapy.
Data indicates that 4 in 10 Americans have at least one tattoo. In this Q&A, board-certified dermatologist Marie Leger, MD, PhD, from Metro Dermatology in New York City, discusses potential dermatologic complications that can arise with tattoos and how dermatologists can manage and treat them.